Predictors of Recurrence for High Risk Endometrial Cancer Patients

  • STATUS
    Recruiting
  • participants needed
    120
  • sponsor
    Far Eastern Memorial Hospital
Send
Updated on 16 February 2024
See if I qualify
cancer
immunomodulators
endometrial cancer

Summary

This study will analyze whether there is any difference in recurrence and survival rates among the patients who received different adjuvant therapies.

Description

The incidence of endometrial cancer is gradually increasing nowaday. The postoperative treatment of high-risk endometrial cancer is also inconsistent. Besides, the recurrence of high-risk endometrial cancer is high. Our retrospective study will analyze the factors associated with recurrence of endometrial cancer, especially for different adjuvant therapies.

Details
Condition High-risk Endometrial Cancer
Age 20years - 100years
Treatment adjuvant therapy
Clinical Study IdentifierNCT04412902
SponsorFar Eastern Memorial Hospital
Last Modified on16 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

All patients with high risk stage I endometrial cancer and all patients with stage II and stage III endometrial cancer and who underwent therapy in Far Eastern Memorial Hospital from 2009/01/01~2019/09/17

Exclusion Criteria

Patients with stage I endometrial cancer do not have high risk factors
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

cancer
immunomodulators
endometrial cancer

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.